Vimarsana
Biggest News Aggregation in the World

Page 2 - Greg Behar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Behar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Behar Today - Breaking & Trending Today

Nestle Health Science CEO Greg Behar to Be Replaced By Anna Mohl - Vimarsana News

Nestle Health Science CEO Greg Behar to Be Replaced By Anna Mohl

By David Sachs Nestle said Friday that Greg Behar, chief executive officer of its food sciences arm, will leave at the end of the year. The Swiss food...

Nestlé Health Science CEO Greg Behar Steps Down, Anna Mohl Named Successor - Vimarsana News

Nestlé Health Science CEO Greg Behar Steps Down, Anna Mohl Named Successor

Greg Behar, the chief executive of Nestlé Health Science, has stepped down from the position. Anna Mohl will succeed Behar in the role.

Nestlé divests its peanut allergy treatment business - Vimarsana News

Nestlé divests its peanut allergy treatment business

Nestlé has divested Palforzia, its peanut allergy treatment business, to Stallergenes Greer, a biopharmaceutical company.

Nestlé Divests Palforzia Business - Vimarsana News

Nestlé Divests Palforzia Business

Peanut allergy treatment business divested to Stallergenes Greer.

Nestlé Sells Peanut Allergy Drug, Ending the Food Giant's Foray Into Biotech - Vimarsana News

Nestlé Sells Peanut Allergy Drug, Ending the Food Giant's Foray Into Biotech

Peanut allergy therapy Palforzia, which Nestlé acquired in a multi-billion dollar deal, has been sold to allergy product company Stallergenes Greer. Palforzia was the first FDA-approved drug for peanut allergy, but its sales were hampered by the Covid-19 pandemic.